Effect of fructose 1,6-bisphosphate on the activity of liver pyruvate kinase aftter limited proteolysis with cathepsin B

Effect of fructose 1,6-bisphosphate on the activity of liver pyruvate kinase aftter limited proteolysis with cathepsin B

BIOCHEMICAL Vol. 110, No. 2, 1983 January 27, 1983 AND BIOPHYSICAL Pages EFFECT OF FRUCTOSE 1,6-BISPHOSPHATE KINASE AFTER LIMITED Noboru Faculty R...

311KB Sizes 0 Downloads 36 Views

BIOCHEMICAL

Vol. 110, No. 2, 1983 January 27, 1983

AND BIOPHYSICAL

Pages

EFFECT OF FRUCTOSE 1,6-BISPHOSPHATE KINASE AFTER LIMITED Noboru Faculty Received

RESEARCH COMMUNICATIONS

Nakai,*

Yutaka

ON THE ACTIVITY

682-687

OF LIVER PYRUVATE

PROTEOLYSIS WITH CATHEPSIN B

Fujii,

Kyoichi

Kobashi

and Jun'ichi

Hase

of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyam-shi, Toyama 930-01,JAPAN December

10, 1982

Treatment of rat liver-type pyruvate kinase with rabbit liver cathepsin B at pH 7.0 caused loss of activity in the standard assay with 0.6 mM of phosphoenolpyruvate. The modified enzyme exhibited about 10% of the original activity when assayed with 2.0 mM of the substrate. No detectable change in the subunit molecular weight of the enzyme occured during inactivation. Cn addition of 4 uM fructose 1,6-bisphosphate the activity of the treated enzyme was restored to that of the original enzyme. Limited proteolysis of the enzyme by cathepsin B appears to enhance the requirement for the positive effector, fructose 1,6-bisphosphate. Limited

proteolysis

of enzyme molecules

considered

to be an initial

contribute

to the regulation

is defined

as the hydrolase

arginine-p-nitroanilide

of protein

stage

for

hemoglobin

(l),

glycolysis

such as glucokinase,

most protein

substrates

it appears

shown

cathepsin

cleavage

result

of the limited

subunit

molecule Pyruvate

catalyzes

without

and to modify

loss

may also

Cathepsin

to inactivate

fructose

kinase

Fru-Pz

that

is

B (EC 3.4.22.1) o-N-benzoyl-DL-

a-N-benzoyl-DL-arginine-g-naphtylamide

and has been reported

that

proteinases

cl-N-benzoyl-L-arginineamide,

and pyruvate

We have

tissue

degradation

of enzyme activity.

(BAPA),

(1)

with

to act

(Fru-Pn)

rabbit for

fructose

in

aldolase

1,6-bisphosphatase

B inactivated

near

involved

(2).

as a peptidyldipeptidase

of the activity

proteolysis

some enzymes

1,6-bisphosphate fructose

and

With

(3-5).

muscle

aldolase

for

l-phosphate

the carboxyl-terminal

region

as a of the

(6). kinase

(ATP:

a key reaction

*Present address: Department Fukui 910-11 JAPAN

pyruvate

2-0-phosphotransferase,

in glycolytic

pathway,

of Chemistry,

0006-291X/83/020682-06$01.50/0 Copyright 0 1983 by Academic Press, Inc. All rights of reproduction in any form reserved.

682

Fukui

EC 2.7.1.40)

and the activity Medical

School,

of the liverMatsuoka,

Vol. 110, No. 2, 1983

type

enzyme,

Fru-Pz

but

BIOCHEMICAL

not

the muscle-type

enzyme,

RESEARCH COMMUNICATIONS

has been shown

to be affected

by

(7). In the present

pyruvate greatly

AND BIOPHYSICAL

kinase enhanced

paper

for

we report

the allosteric

by limited

that

the requirement

effector,

proteolysis MATERIALS

with

fructose cathepsin

of the liver-type 1,6-bisphosphate

is

B.

AND METHODS

NADH, Fru-Pz and BAPA were obtained from Boehringer-Mannheim. Reagents: Phosphoenolpyruvate cyclohexylammonium salt and sodium ADP were purchased All other reagents were of the highest grade from Oriental Yeast Co. Japan. available.

Preparation of enzymes: Rat liverand muscle-type pyruvate kinases were prepared from the tissues of the animals fed on a high carbohydrate diet (8) according to the method of Harada --et al. (9). The enzymes preparations showed a single band on polyacrylamide slab gel electrophoresis in the presence of SDS. Specific activities of liverand muscle-type of enzymes were 200 and 240 unitsjmg protein, respectively. These preparations were dissolved in 10 mM potassium phosphate buffer, pH 6.0, containing 5 mM each of 2-mercaptoethanol and MgS04, and then dialyzed aginst the same buffer in order to remove Fru-Pz completely. Rabbit muscle-type pyruvate kinase was obtained from Boehringer-Mannheim and was dissolved and dialyzed as described above. Cathepsin B from rabbit liver was prepared as described (6), the specific activity was 2.5 unitsfmg protein. Assay of enzymes: Except where otherwise indicated, pyruvate kinase activity was measured with a coupled assay system using lactate dehydrogenase (rabbit muscle-type: Boehringer-Mannheim) similar to that described by Harada --et al. The assay mixture contained final concentrations of 50 mM Tris-HCl (6). buffer, pH 7.4, 100 mM KCl, 5 mM MgS04, 2 mM ADP, 0.2 mM NADN, 2 mM phosphoenolpyruvate and 4.6 units of lactate dehydrogenase in a total volume of 1.0 ml. The decrease in absorbance of NADH at 340 nm was measured at 30°C, using a Gilford 250 multiple spectrophotometer. One unit of pyruvate kinase was defined as the amount of enzyme that caused the oxidation of 1 umole of NADH per min. The activity of cathepsin B was measured with 0.1 M sodium phosphate buffer, pH 6.5, containing 0.8 mM BAPA, 1 mM each of 2-mercaptoethanol and EDTA at 37'C Absorbance of p-nitroaniline released from BAPA by cathepsin B was (1) measured at 410 nm using a Hitachi 100-10 spectrophotometer. One unit of cathepsin B was defined as the amount of enzyme that released 1 pmole of p-nitroaniline per hr.

The reactin of pyruvate Treatment of pyruvate kinase with cathepsin B: kinase with cathepsin B was carried out at 30°C in 0.2 M triethanolamineacetate buffer at indicated pHs in the presence of 5 mM each of Z-mercaptoethanol and EDTA. Protein determination: of Lowry --et al. (10)

using

Protein concentrations bovine serum albumin

were determined as a standard.

by the method

Electrophoresis: SDS polyacrylamide slab gel electrophoresis was carried by the method of Laemmli (11). The gel was stained with 0.2% Coomassie brilliant blue and scanned at 580 nm with a Gilford 250 multiple spectrophotometric gel scanner. 683

out

Vol. 110, No. 2, 1983

BIOCHEMICAL

AND BIOPHYSICAL

RESEARCH COMMUNICATIONS

RESULTS Figure after

1 shows the effect

incubation

pyruvate

with

kinase

at 3O'C.

cathepsin

was stable

Modification

The activities cathepsin

and rabbit

of phosphoenolpyruvate cathepsin below

by cathepsin

B exhibited to that

of the original

for 0.17

mM and that

of the

enzyme

the activity

From Lineweaver-Burk

phosphoenolpyruvate

type

(Fig.

in the presence treated.enzyme

of curve (Fig.

with

ZC),

treated

6

7

6

a Hill

coefficient

and in the presence

of of

of the untreated

was calculated B was 0.27

10’

PH

Fig. 1. Loss of activity of liver-type pyruvate kinase, measured under standard assay condition, on digestion with cathepsin B at several pHs. Rat liver pyruvate kinase (0.225 unit/ml) was incubated with (closed circles) and without (open circles) cathepsin B (0.05 unit/ml) as described in MATERIALS AND METHODS. Relative inactivation is shown by the line (-X-). 684

modified

the Km of the native

cathepsin

9

was

of 4 pM Fru-P2

-100

5

with

kinase

to that

of 4 pM Fru-P2 with

of the concentration

pyruvate

ZB),

by

shown).

The addition

was identical

plots

not affected

enzyme activity

activation;

a hyperbolic

pH.

of phophoenolpyruvate

10% of the original

remarkable

1.0 mM phophoenolpyruvate

not

The enzyme

of 2.0 x1$4substrate.

caused

(data

30 min

at neutral

were

as a function

2.4.

Liver

for

B was rapid

at concentrations

approximately

system

enzyme.

in Fig.

activity

in the presence

kinase

incubation

kinases

above

kinase

buffer.

after

pyruvate

described

pyruvate

little

to the assay

1.2 similar

pH region

muscle

is shown

B showed

0.6 mM, but

observed

at neutral

of liver

pyruvate

B in triethanolamine-acetate

the condition

The activity

of liver

of the enzyme by cathepsin

of rat B under

of pH on the activity

mM.

enzyme to be

Vol. 110, No. 2, 1983

old _,_

BIOCHEMICAL

AND BIOPHYSICAL

RESEARCH COMMUNICATIONS

_-*----- *./---a 2.0

1.0

fPEP,mMl

-1

l/(PEP,mhll

-05

1 0

1 05

logfPEP,mhV)

Fig. 2. Effect of Fru-Pz on the inactivated liver-type pyruvate kinase with cathepsin B (0.05 unit/ml) at pH 7.0 for 2 hr at 30'. (A); The modified enzyme (closed circles) and the original enzyme (open circles) were assayed at various concentrations of phosphoenolpyruvate in the presence (solid line) and the absence (dotted line) of 4 uM Fru-Pa. Other assay conditions were as described in MATERIALS AND METHODS. (B); Lineweaver-Burk plots obtained from data of (C); Replots of data from (A) for calculation of the (A). Hill coefficients.

In

weight

order

to

of the

gel

electrophoresis

lar

weight

were

determine

whether

enzyme subunits, (Fig. observed

3). during

cathepsin

the modified

B

caused

a change

enzyme was subjected

No significant

changes

in

to SDS slab

the subunit

the modification.

Fig. 3. SDS polyacrylamide (15%) slab gel electrophoretic patterns of the native and modified pyruvate kinases. was treated with cathepsin Liver pyruvate kinase (0.61 rag/ml) B (0.05 mg/ml) at pH 7.0. Cathepsin B, native pyruvate kinase and 50% and 80% "inactivated" enzymes were analyzed dn SDS slab gels. (A); Cathepsin B, (B); native enzyme, (C) and (D); 50% and 80% "inactivated" enzymes, respectively. 685

in molecular

molecu-

Vol. 110, No. 2, 1983

BIOCHEMICAL

AND BIOPHYSICAL

RESEARCH COMMUNICATIONS

DISCUSSION The pH optimum for

hydrolysis

of synthetic

as hemoglobin tentatively

of cathepsin

(1).

of fructose

modification

of liver

Thus,

the difference

enzymes may depend which

may also

kinase

activity. Under

also

the lack

the standard

assay liver

of 1.0 mM substrate. kinase,

enzyme completely of the proteolytic

buffer was 5.0

for

observed reactivated Limited

appears dependent

modification

kinase with

the native

a change

modifier, kinase

mM) of

B showed

Unexpectedly, in

that Fru-Pz.

by cathepsin

The nature B is now under

ACKNOWLEDGEMENT thank Professor T. Tanaka and his colleagues University for their helpful suggestion with crystalline rat liver-type pyruvate kinase. B.L. Horecker of Roche Institute of Molecular suggestion in preparation of the manuscript.

of School of respect to We are also Biology for

REFFERENCES 1. 2. 2: 5.

Otto, K. (1971) in Tissue Proteinases (Barrett, A.J. and Dingle, J.J., eds), pp. l-28, North Holland Publishing Co., Amsterdam. Nakashima, K. and Ogino, K. (1974) J. Biochem. 2, 355-365. Aronson, N.N.Jr. and Barrett, A.J. (1978) Biochem. J. 171, 759-765. Bond, J.S. and Barrett, A.J. (1980) Biochem. J. 189, 17-25. Hannappel, E., MacGregor, J.S., Stephen, D. and Horecker, B.L. (1982) Arch. Biochem. Biophys. 214, 293-298. 686

of

makes the

investigation.

We wish to Medicine, Osaka preparation of indebted to Dr. his advice and

the

the presence

at the COOH-terminus

in conformation

on the allosteric of pyruvate

cathepsin

of Fru-Pz

probably

enzyme.

pyruvate

(2.0

enzyme.

by the addition

at

proteins,

B on muscle

with

the

of these

concentration

treated

for

the native

modification

high

was

effective

of the substrate

with

such

In contrast,

for

of cathepsin

proteolysis,

to cause

stability

structure

condition

pyruvate

(2).

6.5

proteins

and that

B was most

proteolytic

of effect

for

region;

of aldolase (6),

by cathepsin

on the quarternary

enzyme was fully

pyruvate

the inactivation

the pH of greatest

10% of the activity

modified

kinase

in pH optima

explain

phosphoenolpyruvate, about

is

pH for

1,6-bisphosphatase pyruvate

to be acidic

such as BAPA and 4.5

to be 5.3 in a citrate

modification

pH, which

substrates

The optimal

determined

neutral

B has been reported

Vol. 110, No. 2, 1983

6. 7. 8. 9. 10. 11.

BIOCHEMICAL

AND BIOPHYSICAL

RESEARCH COMMUNlCATlONS

K. and Hase, J. (1978) Biochem. Biophys. Nakai, N., Wada, K., Kobashi, Res. Communs. 83, 881-885. Bailry, E., Stirpe, F. and Taylor. C.B. (1968) Biochem. J. 108, 427-436. Tanaka, T., Harano, Y., Sue, F. and Morimura, H. (1967) J. Biochem. 62, 71-91. Harada, K., Saheki, S. Wada, K. and Tanaka, T. (1978) Biochim. Biophys. Acta 534, 327-339. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) J. Biol. Chem. 193, 265-275. Laemmli, U.K. (1970) Nature (London) 227, 680-685.

687